R1 RCM (NASDAQ:RCM) Posts Quarterly Earnings Results, Misses Expectations By $0.04 EPS

R1 RCM (NASDAQ:RCM) posted its quarterly earnings data on Tuesday. The healthcare provider reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.04), Briefing.com reports. R1 RCM had a negative net margin of 1.68% and a negative return on equity of 1.44%. The company had revenue of $656.80 million for the quarter, compared to the consensus estimate of $640.93 million. The firm’s revenue was up 14.7% on a year-over-year basis.

R1 RCM Stock Up 0.1 %

R1 RCM stock traded up $0.02 during midday trading on Thursday, reaching $14.29. The company’s stock had a trading volume of 180,833 shares, compared to its average volume of 3,466,794. The stock’s 50-day simple moving average is $14.18 and its 200-day simple moving average is $13.29. The stock has a market capitalization of $6.03 billion, a P/E ratio of -95.13 and a beta of 0.84. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.84 and a quick ratio of 1.84. R1 RCM has a 52-week low of $8.87 and a 52-week high of $15.12.

Analyst Ratings Changes

Several brokerages recently weighed in on RCM. Leerink Partnrs downgraded shares of R1 RCM from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Jefferies Financial Group lowered R1 RCM from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Leerink Partners downgraded shares of R1 RCM from an “outperform” rating to a “market perform” rating and dropped their price target for the company from $17.00 to $14.30 in a report on Thursday, August 1st. TD Cowen reissued a “hold” rating and set a $14.30 price objective (down from $20.00) on shares of R1 RCM in a report on Monday, August 5th. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $14.30 target price on shares of R1 RCM in a report on Friday, October 4th. Thirteen analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $15.41.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.